Article Text
Abstract
INTRODUCTION
Blood pressure is the single most important modifiable risk factor for stroke. Key epidemiological data about the relationship between blood pressure and stroke come from both prospective observational (cohort) studies and randomised controlled trials. Cohort studies provide information about the effects of prolonged blood pressure differences between groups of people (MacMahon et al. 1990), while clinical trials provide evidence about the effects of short-term reductions in blood pressure (Collins et al. 1990). Cohort studies in both Western (Prospective Studies Collaboration 1995) and Eastern (Eastern Stroke and Coronary Heart Disease Collaborative Research Group 1998; Asia Pacific Cohort Studies Collaboration 1999) populations have established a strong and direct association between the risk of first-ever stroke and level of blood pressure, with no detectable lower level of blood pressure below which the risk of stroke does not continue to decline (Fig. 1). A similar association is evident among patients who have had
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Long-term Management of Blood Pressure after Stroke
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
- Managing hypertension in 2018: which guideline to follow?
- Blood pressure, cholesterol and cardiovascular disease in Thailand
- Effect of lower sodium intake on health: systematic review and meta-analyses
- Development and internal validation of a multivariable prediction model for 6-year risk of stroke: a cohort study in middle-aged and elderly Chinese population
- Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses
- Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: cohort study of 306 473 UK Biobank participants
- The 2014 hypertension guidelines: implications for patients and practitioners in Asia
- Prevention of neurological disease in later life